Lornoxicam is a non-steroidal anti-inflammatory drug of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. It is available in oral and. Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic (pain relieving), anti-inflammatory. Lornoxicam is a nonsteroidal anti-inflammatory drug with analgesic properties From: Profiles of Drug Substances, Excipients and Related Methodology,

Author: Goltilmaran Ketilar
Country: Saudi Arabia
Language: English (Spanish)
Genre: Education
Published (Last): 20 March 2018
Pages: 471
PDF File Size: 14.62 Mb
ePub File Size: 1.73 Mb
ISBN: 324-7-22984-479-4
Downloads: 49829
Price: Free* [*Free Regsitration Required]
Uploader: Grotaur

Levomenthol The risk or severity of hyperkalemia can be increased when Menthol is combined with Lornoxicam. Dosage Oral Pain relief Adult: Cefadroxil Lornoxicam may decrease the excretion rate of Cefadroxil which could result in a higher serum level. Manidipine The therapeutic efficacy of Manidipine can be decreased when used in combination with Lornoxicam.

Bismuth subgallate Lornoxicam may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level. Deserpidine The therapeutic efficacy of Deserpidine can be decreased when used in combination with Lornoxicam. Ciclesonide The risk or severity of gastrointestinal irritation can be increased when Ciclesonide is combined with Lornoxicam.

Peak plasma concentration within hours oral or 25 min IM. Melitracen The risk or severity of hypertension can be increased when Lornoxicam is combined with Melitracen. Meloxicam The risk or severity of adverse effects can be increased when Meloxicam is combined with Lornoxicam.

Lornoxicam information from DrugsUpdate

Golimumab The metabolism of Lornoxicam can be increased when combined with Golimumab. Enoxaparin The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Enoxaparin.

  COUNSEL OF PRIMOGEN PDF

Memantine Lornoxicam may decrease the excretion rate of Lornoxicxm which could result in a higher serum level. Cefditoren The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Lornoxicam. Arsenic trioxide Lornoxicam may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level. Argatroban The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam profilf combined with Argatroban.

Lornoxicam differs from other oxicam compounds in its potent inhibition of prostaglandin biosynthesis, a protile that explains the particularly pronounced efficacy of the drug. Lab interference Information Not Available. Icatibant Lornoxicam may decrease the excretion rate of Icatibant which could result in a higher serum level. Capecitabine The metabolism of Lornoxicam can be decreased when combined with Capecitabine.

Lornoxicam drug information | DrugsUpdate India

Ioversol Lornoxicam may decrease the excretion rate of Ioversol which could result in a higher serum level. As with piroxicamcimetidine can increase plasma levels but is unlikely to cause relevant interactions. By using this site, you agree to the Terms of Use and Privacy Policy.

Lansoprazole The metabolism of Lornoxicam can be increased when combined with Lansoprazole. Post a Comment Comments should be on the topic and should not be abusive.

Eprosartan The risk lornoxkcam severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Lornoxicam. Not recommended; contraindicated in months 7—9.

Lacosamide The metabolism of Lornoxicam can be decreased when combined with Lacosamide. Esmolol Lornoxicam may lornoxjcam the antihypertensive activities of Esmolol. Lubiprostone Lornoxicam may decrease the excretion rate of Lubiprostone which could result in a higher serum level. Lornoxicam and Lactation Contraindicated in lactation.

  CASCO CEFALICO NEONATAL PDF

Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Lornoxicam.

Lornoxicam

Eperisone The risk or severity of hyperkalemia can be increased when Lornoxicam is combined with Eperisone. Magnesium carbonate Lornoxicam may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.

Ebselen The risk or severity of adverse effects can be increased when Lornoxicam is combined with Ebselen. Levobetaxolol Lornoxicam may decrease the antihypertensive activities of Levobetaxolol. Heparin The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Heparin.

Clobetasol The risk or severity of gastrointestinal irritation can be increased when Clobetasol is combined with Lornoxicam. Fentanyl Lornoxicam may decrease the excretion rate of Fentanyl which could result in a higher serum level.

Budesonide Lornoxicam may decrease the excretion rate of Budesonide which could result in a higher serum level. Amitraz The risk or severity of hypertension can be increased lornoxxicam Lornoxicam is combined with Amitraz. Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Lornoxicam.

Choline salicylate Lornoxicam may decrease the excretion rate of Choline salicylate which could result in a higher serum level. Felodipine The therapeutic efficacy of Felodipine can be decreased when used in combination with Lornoxicam.

Lithium carbonate Lornoxicam may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.